InvestorsHub Logo
Followers 12
Posts 644
Boards Moderated 0
Alias Born 06/12/2013

Re: None

Sunday, 04/05/2020 5:43:29 PM

Sunday, April 05, 2020 5:43:29 PM

Post# of 424036
So real questions moving forward in the near term:

-Where are the generics at in determining bio-equivalence to Vascepa with the FDA?
-Can a settlement with generics be reached per settlement terms with Teva?
-Will AMRN give us some more info or throw us a bone with unaudited Q1 results?
-If the generic launches, will Europe honor Teva's exclusivity rights, thus voiding the 10 year exclusivity?

If someone has access to the full settlement agreement with Teva please post it. If it wasn't for this unknown, I would dump every penny I had in this.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News